← Back to front page
United States · Platforms & data · TipRanks

GenFleet Advances GFH276 Combination Study in RAS-Mutant Cancers

Published by TipRanks · United States 8 h ago
GenFleet Advances GFH276 Combination Study in RAS-Mutant Cancers
TipRanks

Detailed summary

Inc. Class H ( ($HK:2595) ) has issued an announcement. GenFleet Therapeutics (Shanghai) Inc. is advancing GFH276, an oral Pan ...

Read the full article on TipRanks Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tipranks.com)

Also worth reading